And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is relatively modest. We hope to catch up on some reading, hang with a short person or two, take some long strolls with Mrs. Pharmalot, and catch another installment of our “Let’s-see-them-before-they-die” concert series. And what about you? This is a lovely time of year to enjoy the great outdoors. You could putter around your castle and tidy up. Perhaps this is an opportunity to make time for someone special. Or you could answer the help wanted sign at the Federal Reserve; we understand a certain someone in Washington is having trouble finding a good candidate. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Medicare spending would climb by $187 billion and Medicaid by $7 billion over the next decade if the Center for Medicare and Medicaid Services finalizes a rule to repeal the safe harbor for Part D rebates, Modern Healthcare writes, citing an analysis by the Congressional Budget Office. The Trump administration proposed replacing the safe harbor for rebates from prosecution under the anti-kickback statute with a new one for discounts at the point of sale, by January 2020.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy